Launches·October 21, 2026 at 12:00 AM EDT·2 sources
The $15bn ‘viral’ AI start-up changing how American doctors treat patients
Outlets covering it2 in 11 hours
Oct 21, 4 AMOct 21, 3 PM
What happened
- OpenEvidence founder says two-thirds of US physicians use the company’s chatbot.
- The ad-powered tool is prompting debate about how AI affects patient care.
- The start-up is valued at $15bn, according to the headline.
Reported valuation
$15bn
US physicians using the tool
two-thirds
Why it matters
The reported adoption highlights a significant healthcare AI distribution channel while raising patient-care and advertising-related questions for healthcare and technology professionals.
Read more on YouBank
The Newsroom, ranked for your desk
About ninety free sources every ten minutes, one story per event, read for you: bankers, investors, operators and students each get their own desk. Free to start.
Timeline
- First reported by Financial TimesOct 21The $15bn ‘viral’ AI start-up changing how American doctors treat patients
- Ars Technica reportsOct 21The $15 billion ad-powered AI startup your doctor may already be using
Sources (2)
- Financial TimesOct 21The $15bn ‘viral’ AI start-up changing how American doctors treat patients
- Ars TechnicaOct 21The $15 billion ad-powered AI startup your doctor may already be using
Read more on YouBank
The Newsroom, ranked for your desk
About ninety free sources every ten minutes, one story per event, read for you: bankers, investors, operators and students each get their own desk. Free to start.
- Why it matters to youEvery story matched to your watchlist, your contacts and your pipeline.
- Follow developing storiesAn alert, and a push, the moment a story you follow moves.
- Your briefing, read aloudA few minutes each morning with a chapter per story.
- Brief modeSwipe through the day, a 20-second card each.